Contact DMCA Privacy

Robuta

https://pubmed.ncbi.nlm.nih.gov/34379922/
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
CAB-LA was superior to daily oral TDF-FTC in preventing HIV infection among MSM and transgender women. Strategies are needed to prevent INSTI resistance in...
hiv preventioncisgender mentransgender womencabotegravir